Akori Esmel

Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles

S. Miertus, E. Megnassan, V. Frecer, 2015, International journal of molecular sciences.

Insight into binding mode of nitrile inhibitors of Plasmodium falciparum Falcipain-3, QSAR and Pharmacophore models, virtual design of new analogues with favorable pharmacokinetic profiles

S. Miertus, Sift Desk Journals Open Access Journals, E. Megnassan, 2017 .

Computer-aided Design of Peptidomimetic Inhibitors of falcipain-3: QSAR and Pharmacophore Models

Fidele Ntie-Kang, Boris D. Bekono, Akori Esmel, 2021, Scientia Pharmaceutica.

Design of novel dihydroxynaphthoic acid inhibitors of Plasmodium falciparum lactate dehydrogenase.

S. Miertus, E. Megnassan, V. Frecer, 2012, Medicinal chemistry (Shariqah (United Arab Emirates)).

Computer-assisted Design of Novel Polyketide Synthase 13 of Mycobacterium tuberculosis Inhibitors Using Molecular Modeling and Virtual Screening

E. Megnassan, Mélalie Keita, Akori Esmel, 2022, Journal of Pharmaceutical Research International.

In silico Design of Novel N-hydrosulfonylbenzamides inhibitors of dengue RNA-dependent RNA polymerase showing favorable predicted pharmacokinetic profiles

Mélalie Keita, Affiba Florance Kouassi, Akori Esmel, 2021, SDRP Journal of Computational Chemistry & Molecular Modeling.

Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of Plasmodium falciparum with Favourable ADME Profiles

L. C. Owono, E. Megnassan, V. Frecer, 2023, International journal of molecular sciences.